Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 1986-1992

  Kita, Yoshiaki ^a   Nishizono, Yuka ^a   Okumura, Hiroshi ^a   Uchikado, Yasuto ^a   Sasaki, Ken ^a   Matsumoto, Masataka ^a   Setoyama, Tetsuro ^a   Tanoue, Kiyonori ^a   Omoto, Itaru ^a   Mori, Shinichiro ^a   Owaki, Tetsuhiro ^a   Ishigami, Sumiya ^a   Nakagawa, Hiroshi ^b   Tanaka, Fumiaki ^c   Mimori, Koshi ^c   Mori, Masaki ^d   Natsugoe, Shoji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarker; Cyclin dependent kinase subunit 2; Esophageal squamous cell carcinoma; Prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE 2; MESSENGER RNA; SMALL INTERFERING RNA; CARRIER PROTEIN; CELL CYCLE PROTEIN; CKS2 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISTANT METASTASIS; ENZYME REPRESSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHATIC INVASION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR INVASION; BIOSYNTHESIS; CELL PROLIFERATION; CYTOLOGY; ESOPHAGUS; ESOPHAGUS TUMOR; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 84898605721     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3062     Document Type: Article

References (32)

1. Sugimachi K, Matsuura H, Kai H, Kanematsu T, Inokuchi K and Jingu K: Prognostic factors of esophageal carcinoma: Univariate and multivariate analyses. J Surg Oncol 31: 108-112, 1986
2. Natsugoe S, Matsumoto M, Okumura H, et al: Prognostic factors in patients with submucosal esophageal cancer. J Gastrointest Surg 8: 631-635, 2004
3. Richardson HE, Stueland CS, Thomas J, Russell P and Reed SI: Human cDNAs encoding homologs of the small p34Cdc28/Cdc2-associated protein of Saccharomyces cerevisiae and Schizosaccharomyces pombe. Genes Dev 4: 1332-1344, 1990
4. Bourne Y, Watson MH, Hickey MJ, et al: Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1. Cell 84: 863-874, 1996
5. Ganoth D, Bornstein G, Ko TK, et al: The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27. Nat Cell Biol 3: 321-324, 2001
6. Spruck CH, de Miguel MP, Smith AP, et al: Requirement of Cks2 for the first metaphase/anaphase transition of mammalian meiosis. Science 300: 647-650, 2003
7. Spruck C, Strohmaier H, Watson M, et al: A CDK-independent function of mammalian Cks1: Targeting of SCFSkp2 to the CDK inhibitor p27Kip1. Mol Cell 7: 639-650, 2001
8. Tedesco D, Lukas J and Reed SI: The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Genes Dev 16: 2946-2957, 2002
9. Masuda TA, Inoue H, Sonoda H, et al: Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: Modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62: 3819-3825, 2002
10. Welcker M, Orian A, Jin J, et al: The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci USA 101: 9085-9090, 2004
11. Inui N, Kitagawa K, Miwa S, et al: High expression of Cks1 in human non-small cell lung carcinomas. Biochem Biophys Res Commun 303: 978-984, 2003
12. Wong YF, Cheung TH, Tsao GS, et al: Genome-wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarray. Int J Cancer 118: 2461-2469, 2006
13. Lan Y, Zhang Y, Wang J, Lin C, Ittmann MM and Wang F: Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death. Int J Cancer 123: 543-551, 2008
14. Wang XC, Tian J, Tian LL, et al: Role of Cks1 amplification and overexpression in breast cancer. Biochem Biophys Res Commun 379: 1107-1113, 2009
15. Sobin LH and Fleming ID: TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 80: 1803-1804, 1997
16. Arigami T, Natsugoe S, Uenosono Y, et al: Lymphatic invasion using D2-40 monoclonal antibody and its relationship to lymph node micrometastasis in pN0 gastric cancer. Br J Cancer 93: 688-693, 2005
17. Ogawa K, Utsunomiya T, Mimori K, et al: Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 11: 2889-2893, 2005
18. Uchikado Y, Inoue H, Haraguchi N, et al: Gene expression profiling of lymph node metastasis by oligomicroarray analysis using laser microdissection in esophageal squamous cell carcinoma. Int J Oncol 29: 1337-1347, 2006
19. Kita Y, Mimori K, Iwatsuki M, et al: STC2: A predictive marker for lymph node metastasis in esophageal squamous-cell carcinoma. Ann Surg Oncol 18: 261-272, 2011
20. Tanaka F, Matsuzaki S, Mimori K, Kita Y, Inoue H and Mori M: Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer. Int J Oncol 39: 361-372, 2011
21. Li M, Lin YM, Hasegawa S, et al: Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312, 2004
22. Kawakami K, Enokida H, Tachiwada T, et al: Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling. Oncol Rep 16: 521-531, 2006
23. Chen R, Feng C and Xu Y: Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression. J Int Med Res 39: 533-540, 2011
24. Wang JJ, Fang ZX, Ye HM, et al: Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma. Dis Esophagus 26: 729-736, 2013
25. de Wit NJ, Rijntjes J, Diepstra JH, et al: Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays. Br J Cancer 92: 2249-2261, 2005
26. Rickman DS, Bobek MP, Misek DE, et al: Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 61: 6885-6891, 2001
27. Scrideli CA, Carlotti CG Jr., Okamoto OK, et al: Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: Identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR. J Neurooncol 88: 281-291, 2008
28. Baylin SB and Jones PA: A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer 11: 726-734, 2011
29. He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5: 522-531, 2004
30. Fabbri M, Calore F, Paone A, Galli R and Calin GA: Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol 754: 137-148, 2013
31. Lv M, Zhang X, Li M, et al: MiR-26a and its target CKS2 modulate cell growth and tumorigenesis of papillary thyroid carcinoma. PLoS One 8: E67591, 2013
32. Liberal V, Martinsson-Ahlzen HS, Liberal J, et al: Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins. Proc Natl Acad Sci USA 109: 2754-2759, 2012